NCT07302997 Real-Time Monitoring of the Injection Pressure During the Peripheral Nerve Block
| NCT ID | NCT07302997 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ente Ospedaliero Cantonale, Bellinzona |
| Condition | No Condition |
| Study Type | INTERVENTIONAL |
| Enrollment | 34 participants |
| Start Date | 2025-12-19 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 34 participants in total. It began in 2025-12-19 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial with medical device is to learn if the Smart Needle Monitoring System works to maintain a safe low injection pressure during a type of regional anaesthetic (Peripheral Nerve Block (PNB)) in patients due to undergo surgery below the elbow . It will also learn about the safety of the device and patients' perception of the quality of anesthesia. Participants will: * be operated locally according to standard clinical practice * undergo post-anesthesia recovery and any neurologic symptoms or signs assessment on postoperative days 1 and 7
Eligibility Criteria
Inclusion Criteria: * Informed Consent signed by the subject * Age ≥ 18 years * Scheduled for elective surgery below the elbow (e.g., hand surgery, distal radius surgery, forearm surgery) requiring an axillary block * ASA physical status I-III * Ability to understand the investigation * Ability and willingness to follow and complete the procedures of the investigation Exclusion Criteria: * Contraindications to the axillary block (e.g., local infection) * Refusal of locoregional anesthesia for the surgical procedure * Pre-existing neurologic deficits in the operative extremity * Body Mass Index ≥ 35 kg/m2 * Known allergy to local anesthetic (mepicavaine hydrochloride) * Inability to comply with post-operative evaluations e.g. due to language problems, psychological disorders, dementia, etc. of the subject
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07302997 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying No Condition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07302997 currently recruiting?
Yes, NCT07302997 is actively recruiting participants. Contact the research team at roberto.dossi@eoc.ch for enrollment information.
Where is the NCT07302997 trial being conducted?
This trial is being conducted at Bellinzona, Switzerland.
Who is sponsoring the NCT07302997 clinical trial?
NCT07302997 is sponsored by Ente Ospedaliero Cantonale, Bellinzona. The trial plans to enroll 34 participants.